Underactive Bladder Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 2a, Proof-of-Concept Study of ASP8302 in Subjects With Underactive Bladder
The study objectives of this study are to evaluate the efficacy of ASP8302 compared with placebo in participants with underactive bladder (UAB), to investigate the safety and tolerability of ASP8302 compared with placebo in participants with UAB, to investigate the pharmacokinetics of ASP8302 in participants with UAB and to support the development of the UAB - Patient Reported Outcome (PRO).
The study will comprise a screening visit, followed by a treatment period and a 2-week follow-up period, in total 8 weeks. Participants will visit the clinic at screening (visit 1) and every 2 weeks (visit 2, 3, 4, and 5). During the course of the study assessments will be performed at the visits. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04236596 -
Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention
|
N/A | |
| Not yet recruiting |
NCT05576311 -
Codesign of an Optical Device to Measure Urine Flow and Volume
|
||
| Recruiting |
NCT05485142 -
The Treatment Efficacy of Prolotherapy in Bladder Voiding Dysfunction
|
N/A | |
| Completed |
NCT04473469 -
Previously Implanted Pudendal Nerve Stimulation
|
N/A |